ArticleInternational journal of hematology2018

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial.

Hirohisa Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.